SCHEMBL13694948

SCHEMBL13694948

CC(=O)NC1[C@H](O[C@H](C)[C@H](NC(=O)OC(C)(C)C)C(=O)O)OC(COC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.47
▸ POLB P06746 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.43
▸ CYP3A4 P08684 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ MMP12 P39900 3/20 0.41
▸ CYP2D6 P10635 2/20 0.39
▸ THRB P10828 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MMP9 P14780 2/20 0.37
▸ TSHR P16473 1/20 0.36
▸ TGM2 P21980 1/20 0.36
▸ CA1 P00915 5/20 0.35
▸ CA2 P00918 5/20 0.35
▸ CA9 Q16790 5/20 0.35
▸ CA12 O43570 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16509797 1.00 LMNA (0.49) LMNAKMT2AALDH1A1POLBKDM4E
SCHEMBL13694947 0.87 LMNA (0.57) LMNAKMT2AALDH1A1POLBKDM4E
SCHEMBL16509798 0.87 LMNA (0.57) LMNAKMT2AALDH1A1POLBKDM4E
SCHEMBL17287141 0.83 LMNA (0.51) LMNAKMT2AALDH1A1POLBKDM4E
SCHEMBL17287140 0.83 LMNA (0.51) LMNAKMT2AALDH1A1POLBKDM4E
SCHEMBL23077722 0.83 LMNA (0.51) LMNAKMT2AALDH1A1POLBKDM4E
SCHEMBL1737712 0.81 LMNA (0.53) LMNAKMT2AALDH1A1POLBKDM4E
SCHEMBL15910280 0.81 LMNA (0.53) LMNAKMT2AALDH1A1POLBKDM4E
SCHEMBL14031247 0.81 LMNA (0.56) LMNAKMT2AALDH1A1POLBKDM4E
SCHEMBL14049596 0.81 LMNA (0.56) LMNAKMT2AALDH1A1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8076299-B2 Method for producing peptide thioester RIKEN (JP) 2011-12-13 — — US disclosed
US-20090240034-A1 METHOD FOR PRODUCING PEPTIDE THIOESTER RIKEN (JP) 2009-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240034-A1 METHOD FOR PRODUCING PEPTIDE THIOESTER PTMS, PPT1, NGLY1 LMNA 4397/4885KMT2A 1579/4885ALDH1A1 4214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback